RedHill Biopharma Announces Initiation of Phase IIa Study with ABC294640 (YELIVA
- This topic has 0 replies, 1 voice, and was last updated 6 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
RedHill Biopharma Announces Initiation of Phase IIa Study with ABC294640 (YELIVA®) for Cholangiocarcinoma at Mayo Clinic and MD Anderson
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.